These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11749604)

  • 1. Efficient and versatile synthesis of novel 2alpha-substituted 1alpha,25-dihydroxyvitamin D(3) analogues and their docking to vitamin D receptors.
    Suhara Y; Nihei KI; Kurihara M; Kittaka A; Yamaguchi K; Fujishima T; Konno K; Miyata N; Takayama H
    J Org Chem; 2001 Dec; 66(26):8760-71. PubMed ID: 11749604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2-Ethyl and 2-ethylidene analogues of 1alpha,25-dihydroxy-19-norvitamin D(3): synthesis, conformational analysis, biological activities, and docking to the modeled rVDR ligand binding domain.
    Sicinski RR; Rotkiewicz P; Kolinski A; Sicinska W; Prahl JM; Smith CM; DeLuca HF
    J Med Chem; 2002 Aug; 45(16):3366-80. PubMed ID: 12139448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular structure of the rat vitamin D receptor ligand binding domain complexed with 2-carbon-substituted vitamin D3 hormone analogues and a LXXLL-containing coactivator peptide.
    Vanhooke JL; Benning MM; Bauer CB; Pike JW; DeLuca HF
    Biochemistry; 2004 Apr; 43(14):4101-10. PubMed ID: 15065852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concise synthesis and biological activities of 2alpha-alkyl- and 2alpha-(omega-hydroxyalkyl)-20-epi-1alpha,25-dihydroxyvitamin D3.
    Honzawa S; Suhara Y; Nihei K; Saito N; Kishimoto S; Fujishima T; Kurihara M; Sugiura T; Waku K; Takayama H; Kittaka A
    Bioorg Med Chem Lett; 2003 Oct; 13(20):3503-6. PubMed ID: 14505658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Syntheses and biological evaluation of novel 2alpha-substituted 1alpha,25-dihydroxyvitamin D3 analogues.
    Suhara Y; Nihei KI; Tanigawa H; Fujishima T; Konno K; Nakagawa K; Okano T; Takayama H
    Bioorg Med Chem Lett; 2000 May; 10(10):1129-32. PubMed ID: 10843234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and synthesis of 2α-(tetrazolylethyl)-1α,25-dihydroxyvitamin D3 as a high affinity ligand for vitamin D receptor.
    Matsuo M; Hasegawa A; Takano M; Saito H; Kakuda S; Takagi K; Ochiai E; Horie K; Takimoto-Kamimura M; Takenouchi K; Sawada D; Kittaka A
    J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt A():201-3. PubMed ID: 24036313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A concise and efficient route to 2alpha-(omega-hydroxyalkoxy)-1alpha,25-dihydroxyvi tam in D3: remarkably high affinity to vitamin D receptor.
    Kittaka A; Suhara Y; Takayanagi H; Fujishima T; Kurihara M; Takayama H
    Org Lett; 2000 Aug; 2(17):2619-22. PubMed ID: 10990411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functionalization at C-12 of 1alpha,25-dihydroxyvitamin D(3) strongly modulates the affinity for the vitamin D receptor (VDR).
    González-Avión XC; Mouriño A
    Org Lett; 2003 Jun; 5(13):2291-3. PubMed ID: 12816431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of 2α- and 2β-(3-hydroxypropyl)- 7,8-cis-14-epi-1α,25-dihydroxy-19-norvitamin D
    Sawada D; Ochiai E; Takeuchi A; Kakuda S; Kamimura-Takimoto M; Kawagoe F; Kittaka A
    J Steroid Biochem Mol Biol; 2017 Oct; 173():79-82. PubMed ID: 27629592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fine tuning of agonistic/antagonistic activity for vitamin D receptor by 22-alkyl chain length of ligands: 22S-Hexyl compound unexpectedly restored agonistic activity.
    Anami Y; Sakamaki Y; Itoh T; Inaba Y; Nakabayashi M; Ikura T; Ito N; Yamamoto K
    Bioorg Med Chem; 2015 Nov; 23(22):7274-81. PubMed ID: 26515040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, metabolism, and biological activity of 2-[3-(tetrazolyl)propyl]-1α,25-dihydroxy-19-norvitamin D
    Takano M; Yasuda K; Higuchi E; Tohyama E; Takeuchi A; Sakaki T; Kittaka A
    J Steroid Biochem Mol Biol; 2016 Nov; 164():40-44. PubMed ID: 26232635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New C15-substituted active vitamin D3.
    Shindo K; Kumagai G; Takano M; Sawada D; Saito N; Saito H; Kakuda S; Takagi K; Ochiai E; Horie K; Takimoto-Kamimura M; Ishizuka S; Takenouchi K; Kittaka A
    Org Lett; 2011 Jun; 13(11):2852-5. PubMed ID: 21539305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 13,13-Dimethyl-des-C,D analogues of (20S)-1α,25-dihydroxy-2-methylene-19-norvitamin D₃ (2MD): total synthesis, docking to the VDR, and biological evaluation.
    Plonska-Ocypa K; Sibilska I; Sicinski RR; Sicinska W; Plum LA; DeLuca HF
    Bioorg Med Chem; 2011 Dec; 19(23):7205-20. PubMed ID: 22018918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and testing of 2alpha-modified 1alpha,25-dihydroxyvitamin D(3) analogues with a double side chain: marked cell differentiation activity.
    Suhara Y; Kittaka A; Kishimoto S; Calverley MJ; Fujishima T; Saito N; Sugiura T; Waku K; Takayama H
    Bioorg Med Chem Lett; 2002 Nov; 12(22):3255-8. PubMed ID: 12392726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ligand-specific structural changes in the vitamin D receptor in solution.
    Singarapu KK; Zhu J; Tonelli M; Rao H; Assadi-Porter FM; Westler WM; DeLuca HF; Markley JL
    Biochemistry; 2011 Dec; 50(51):11025-33. PubMed ID: 22112050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2-Methylene analogs of 1alpha-hydroxy-19-norvitamin D3: synthesis, biological activities and docking to the ligand binding domain of the rat vitamin D receptor.
    Grzywacz P; Plum LA; Sicinska W; Sicinski RR; Prahl JM; DeLuca HF
    J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):13-7. PubMed ID: 15225739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new class of vitamin D analogues that induce structural rearrangement of the ligand-binding pocket of the receptor.
    Inaba Y; Yoshimoto N; Sakamaki Y; Nakabayashi M; Ikura T; Tamamura H; Ito N; Shimizu M; Yamamoto K
    J Med Chem; 2009 Mar; 52(5):1438-49. PubMed ID: 19193059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel 1alpha,25-dihydroxyvitamin D3 analogues with the side chain at C12.
    González-Avión XC; Mouriño A; Rochel N; Moras D
    J Med Chem; 2006 Mar; 49(5):1509-16. PubMed ID: 16509569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New derivatives of 1alpha,25-dihydroxy-19-norvitamin D3 with two substituents at C-2: synthesis and biological activity.
    Shimizu M; Iwasaki Y; Shimazaki M; Amano Y; Yamamoto K; Reischl W; Yamada S
    Bioorg Med Chem Lett; 2005 Mar; 15(5):1451-5. PubMed ID: 15713405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological evaluation of a des-C,D-analog of 2-methylene-19-nor-1alpha,25-(OH)2D3.
    Plonska-Ocypa K; Grzywacz P; Sicinski RR; Plum LA; DeLuca HF
    J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):298-304. PubMed ID: 17223343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.